These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3137388)

  • 21. Role of the nurse in thrombolytic therapy.
    Albarran J; Kapeluch H
    Br J Nurs; 1994 Feb 10-23; 3(3):104-9. PubMed ID: 8148624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombolytic therapy for acute myocardial infarction--round 2.
    Lancet; 1988 Mar; 1(8585):565-7. PubMed ID: 2894496
    [No Abstract]   [Full Text] [Related]  

  • 23. Case history: successful thrombolytic therapy in a patient with acute myocardial infarction.
    Sait YR
    Heart Lung; 1988 Nov; 17(6 Pt 2):782-6. PubMed ID: 3142824
    [No Abstract]   [Full Text] [Related]  

  • 24. Coronary thrombolysis in patients with acute myocardial infarction by intravenous infusion of synergic thrombolytic agents.
    Collen D; Stump DC; Van de Werf F
    Am Heart J; 1986 Nov; 112(5):1083-4. PubMed ID: 3096127
    [No Abstract]   [Full Text] [Related]  

  • 25. Early intravenous thrombolytic therapy for acute myocardial infarction in patients with prior coronary artery bypass grafts.
    Kleiman NS; Berman DA; Gaston WR; Cashion R; Roberts R
    Am J Cardiol; 1989 Jan; 63(1):102-4. PubMed ID: 2491770
    [No Abstract]   [Full Text] [Related]  

  • 26. Pericardial effusion after intravenous recombinant tissue-type plasminogen activator for acute myocardial infarction.
    Belkin RN; Mark DB; Aronson L; Szwed H; Califf RM; Kisslo J
    Am J Cardiol; 1991 Mar; 67(6):496-500. PubMed ID: 1900139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombolytic therapy update.
    Sipperly ME
    Crit Care Nurse; 1985; 5(6):30-4. PubMed ID: 3936680
    [No Abstract]   [Full Text] [Related]  

  • 28. [Thrombolytic agents, urokinase, tissue-type plasminogen activator and pro-urokinase--their routes of administration and dosage: comparison between intracoronary thrombolysis and intravenous coronary thrombolysis].
    Motomiya T
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():441-5. PubMed ID: 12735012
    [No Abstract]   [Full Text] [Related]  

  • 29. Reteplase.
    Dimens Crit Care Nurs; 1999; 18(6):23. PubMed ID: 10640049
    [No Abstract]   [Full Text] [Related]  

  • 30. Acute myocardial infarction and the use of thrombolytic therapy.
    Betts B
    Qld Nurse; 1989; 8(2):12-4. PubMed ID: 2501830
    [No Abstract]   [Full Text] [Related]  

  • 31. Drugs that dissolve clots.
    Braun AE
    RN; 1991 Jun; 54(6):52-7. PubMed ID: 1903557
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial.
    Cannon CP; McCabe CH; Diver DJ; Herson S; Greene RM; Shah PK; Sequeira RF; Leya F; Kirshenbaum JM; Magorien RD
    J Am Coll Cardiol; 1994 Dec; 24(7):1602-10. PubMed ID: 7963104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombolytic therapy: a case study.
    Moseley MJ
    Crit Care Nurse; 1992 Mar; 12(3):62-8. PubMed ID: 1559384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What you should know about thrombolytic therapy for acute MI.
    Aragon D; Martin M
    Am J Nurs; 1993 Sep; 93(9):24-31; quiz 33. PubMed ID: 8213959
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of tissue plasminogen activator therapy on the frequency of acute right ventricular myocardial infarction associated with acute left ventricular infarction.
    Kalan JM; Gertz SD; Kragel AH; Berger PB; Roberts WC; Ryan TJ
    Int J Cardiol; 1993 Feb; 38(2):151-8. PubMed ID: 8454377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preventing coronary artery reocclusion following t-PA.
    Sylvain Moore H
    Crit Care Nurse; 1990; 10(10):52-8. PubMed ID: 2123427
    [No Abstract]   [Full Text] [Related]  

  • 37. Dysrhythmias and blood pressure changes associated with thrombolysis.
    Lepley-Frey D
    Heart Lung; 1991 Jul; 20(4):335-41. PubMed ID: 1906443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous thrombolytic therapy in myocardial infarction: an analytical review.
    Shammas NW; Zeitler R; Fitzpatrick P
    Clin Cardiol; 1993 Apr; 16(4):283-92. PubMed ID: 8458108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paraplegia subsequent to administration of tissue plasminogen activator and intravenous heparin following myocardial infarction--a case report.
    DePorto R; Ahn JH; Gianutsos JG
    J Spinal Cord Med; 2000; 23(2):150-2. PubMed ID: 10914357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapy of acute myocardial infarction in the 1990s.
    Flores ED; Lange RA; Cigarroa RG; Hillis LD
    Am J Med Sci; 1990 Jun; 299(6):415-24. PubMed ID: 2113353
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.